PIC Therapeutics: Funding, Investors & Team (Oct 2026)
PIC Therapeutics is a biotechnology company focused on transforming the treatment of cancer through the selective modulation of oncogene translation. The company is modulating oncogene translation to dramatically improve cancer patient outcomes. Their precision-based therapeutics target the “master switch” of cancer signaling pathways, selectively blocking oncogene protein production by modulating the Pre-Initiation Complex (PIC) that drives their mRNA translation. Its selective approach has the potential to simultaneously modulate multiple oncogenic drivers leading to a powerful new generation of cancer-treating therapeutics. PIC Therapeutics was founded in 2016 and is headquartered in
PIC Therapeutics has raised $40.0M across 2 funding rounds on record, the most recent a Series A of $35.0M announced in Oct 2022.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
PIC Therapeutics Company Profile and Key Stats
Latest funding round on record: Oct 2022.
PIC Therapeutics Funding Rounds
PIC Therapeutics raised $5.0M in an undisclosed round announced in Apr 2020.
2.5 years later, a Series A of $35.0M was announced in Oct 2022.
PIC Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
PIC Therapeutics Funding Compared to Other Biotechnology Startups
PIC Therapeutics' latest round of $35.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like PIC Therapeutics in Biotechnology and Natick
Companies Similar to PIC Therapeutics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
PIC Therapeutics Funding FAQs
What does PIC Therapeutics do?
PIC Therapeutics is a biotechnology company focused on transforming the treatment of cancer through the selective modulation of oncogene translation. The company is modulating oncogene translation to dramatically improve cancer patient outcomes. Their precision-based therapeutics target the “master switch” of cancer signaling pathways, selectively blocking oncogene protein production by modulating the Pre-Initiation Complex (PIC) that drives their mRNA translation. Its selective approach has the potential to simultaneously modulate multiple oncogenic drivers leading to a powerful new generation of cancer-treating therapeutics. PIC Therapeutics was founded in 2016 and is headquartered in
How much funding has PIC Therapeutics raised?
PIC Therapeutics has raised $40.0M across 2 rounds on record. The most recent is a Series A of $35.0M announced in Oct 2022.
When did PIC Therapeutics last raise funding?
PIC Therapeutics' most recent funding round on record is a Series A of $35.0M, announced in Oct 2022.
Who is the CEO of PIC Therapeutics?
Katherine S Bowdish is listed as CEO at PIC Therapeutics.
Where is PIC Therapeutics headquartered?
PIC Therapeutics is based in Natick, Massachusetts, United States.
How many employees does PIC Therapeutics have?
PIC Therapeutics is in the 1-10 employee band.
How does PIC Therapeutics' funding compare to other Biotechnology startups?
PIC Therapeutics' latest round of $35.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's PIC Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for PIC Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.